No New Meds

No New Meds

With drug firms in retreat, the pipeline for new psychiatric medications dries up

By Laura Sanders, 11:45 AM February 7, 2013

Psychiatry seemed poised on the edge of a breakthrough. In early 2011, after decades of no radically new drugs, a fundamentally different schizophrenia treatment promised relief from the psychotic hallucinations and delusions plaguing people with the disease. The new compound, devised by chemists at Eli Lilly and Co., hit a target in the brain that older medicines had ignored.


All signs pointed to success. In mice, a similar molecule could block the schizophrenia-like effects of PCP. In peopl...

Source URL: